FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS

🇮🇹Italy

Country: 🇮🇹Italy

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Comparison Between Two Different Distention Medium in Diagnostic Hysteroscopy

Not Applicable

Completed

Conditions: Hysteroscopy, Distension Medium, Pain

Interventions: Procedure: diagnostic hysteroscopy
Drug: carbon dioxide
Drug: physiological solution

First Posted Date: 2016-11-08

Last Posted Date: 2017-10-06

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 2000

Registration Number: NCT02958722

Laparoscopic Sacrocolpopexy Versus POPS in the Management of Pelvic Prolapse

Not Applicable

Completed

Conditions: Pelvic Organ Prolapse

Interventions: Procedure: Laparoscopic procedure

First Posted Date: 2016-09-22

Last Posted Date: 2017-12-06

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 30

Registration Number: NCT02911584

Trial on Trabectedin (ET-743) vs Clinician's Choice Chemotherapy in Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancers of BRCA Mutated or BRCAness Phenotype Patients

Phase 3

Completed

Conditions: Ovarian Neoplasms

Interventions: Drug: Pegylated Liposomal Doxorubicin
Drug: Trabectedin
Drug: Topotecan
Drug: Gemcitabine
Drug: Weekly Paclitaxel
Drug: Carboplatin

First Posted Date: 2016-09-16

Last Posted Date: 2021-08-25

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 242

Registration Number: NCT02903004

Locations: 🇮🇹
Domenica Lorusso, Rome, Italy

The Effects of Beclomethasone Upper the Endotracheal Cuff on the Occurrence of Sore Throat at Extubation

Phase 4

Withdrawn

Conditions: Anesthesia, Endotracheal

Interventions: Drug: Beclomethasone
Drug: Placebo

First Posted Date: 2016-02-22

Last Posted Date: 2021-02-25

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Registration Number: NCT02687100

Ranolazine a Potential New Therapeutic Application

Phase 4

Withdrawn

Conditions: Myocardial Stunning

Interventions: Drug: Placebo
Drug: Ranolazine

First Posted Date: 2016-02-22

Last Posted Date: 2021-02-25

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Registration Number: NCT02687269

Glucose Metabolism, Muscle Mass/Function and Inflammation in the Elderly

Completed

Conditions: Diabetes Mellitus
Sarcopenia

First Posted Date: 2015-04-24

Last Posted Date: 2023-04-19

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 76

Registration Number: NCT02426073

Locations: 🇮🇹
Ospedale San Giovanni Calibita - Fatebenefratelli Isola Tiberina, Rome, Italy
🇮🇹
Catholic University of Sacred Heart, Rome, Italy

Investigating Predictive Factors of Diabetes Occurence After Duodenalpancreatectomy

Recruiting

Conditions: GLUCOSE METABOLISM
PANCREATIC ISLETS
Exocrine Pancreatic Insufficiency
DIABETES
Exocrine Pancreatic Dysfunction
Exocrine Pancreas Conditions
Endocrine Pancreas Disorder

First Posted Date: 2014-06-26

Last Posted Date: 2024-05-23

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 100

Registration Number: NCT02175459

Locations: 🇮🇹
Endocrinology - Catholic University, Rome, RM, Italy

Vitamin D Supplementation for the Prevention of Cardiovascular Risk

Phase 4

Completed

Conditions: Obesity
Overweight
Insulin Resistance

Interventions: Drug: Vitamin D
Drug: Placebo (for vitamin D)

First Posted Date: 2013-12-25

Last Posted Date: 2023-04-19

Lead Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Target Recruit Count: 60

Registration Number: NCT02020694

Locations: 🇮🇹
Catholic University of Sacred Heart, Rome, Italy

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy